Creation of the BioBank, Early Detection and Discovery Biomarkers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dianna Larson, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00901680
First received: May 13, 2009
Last updated: August 20, 2012
Last verified: August 2012

May 13, 2009
August 20, 2012
August 2008
January 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00901680 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Creation of the BioBank, Early Detection and Discovery Biomarkers
Creation of the BioBank,To Establish a Multidisciplinary Research Structure That Facilitates Projects That Bridge Specialties That Normally May or May Not Interact.

To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.

To establish a multidisciplinary research structure that facilitates projects that bridge specialties that normally may or may not interact. The tissue bank will build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies in a fast and direct manner. Tissue banks can be used for numerous discovery applications such as the identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization, and validation of biomarkers that are predictive of disease and treatment.

Observational
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Biospecimens to be retained are tissue, blood, whole blood, DNA, RNA, urine saliva,cerebral spinal fluid, amniotic fluid.

Non-Probability Sample

Population male/female from inpatient and outpatient hospital settings or doctor offices..

  • Pancreatic Cancer
  • Head and Neck Cancer
  • Breast Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3028
January 2012
January 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male and female volunteers

Exclusion Criteria:

  • N/A volunteers
Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00901680
HIC 2008-180
No
Dianna Larson, William Beaumont Hospitals
William Beaumont Hospitals
Not Provided
Principal Investigator: George Wilson, PhD William Beaumont Hospitals
William Beaumont Hospitals
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP